Mortality was strongly associated with older age, comorbidities, and infection type, underscoring the need for early and diagnosis-specific antimicrobial intervention.

HealthDay News — For patients with resected stage IIIB-C or stage IV melanoma, recurrence-free survival is longer with nivolumab than ipilimumab, according to a study published online Oct. 18 in the ...

A cohort study of more than 573,000 men identified cognitive traits that may be associated with greater risk of alcohol use disorder.

Low-dose pembrolizumab increased complete pathological response when added to dose-dense taxane backbone in patients with stage II to III triple-negative breast cancer,” said Atul Batra, MD.

Researchers sought to determine whether glofitamab would induce responses in real-world cases of relapsed or refractory DLBCL.

A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.

An overview is presented of the PNSAT, a tool for measuring the value of a navigation program from organizational context to community engagement.

An overview of the role of the navigator, its history and evolution, and the development of practice standards are discussed.

Smaller declines seen in early-stage cancer diagnosis during COVID-19 pandemic in adults aged 18 to 44 years, men, those with high comorbidity burden.

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

Patients with 15-day MRD less than 10% blasts fared better than those with 10% or greater, even if they had other high-risk factors.

Study validates FACIT-Fatigue scale for assessment of cancer-related fatigue in patients with locally advanced/metastatic breast cancer.